Mar 25, 2020
Forge Enters Into Collaboration With Roche To Develop Novel Antibiotic To Treat Lung Infections
Aug 14, 2019
Forge Therapeutics Receives Notice Of Allowance From U.S. Patent And Trademark Office Covering Novel Chemistry Targeting LpxC For The Treatment Of Gram-Negative Bacterial Infections
Mar 12, 2019
Forge Therapeutics To Present At The 18th Annual Needham & Company Healthcare Conference
Apr 09, 2018
Forge Announces Oral Presentation On Development Of Novel Antibiotics At The 28th Annual ECCMID Meeting
Mar 21, 2018
Forge Therapeutics To Present At The 2018 Needham & Company Healthcare Conference
Oct 31, 2017
Forge Therapeutics And Collaborators From Evotec And USC Present New Efficacy Data At 2017 Keystone Symposia Conference
Oct 24, 2017
Forge Therapeutics Announces Participation In Upcoming Scientific And Industry Events
Oct 11, 2017
Forge Therapeutics To Participate In Antimicrobial Resistance Panel At 2017 BIO Investor Forum
Sep 12, 2017
Forge Therapeutics To Present At World Anti-Microbial Resistance Congress 2017
Sep 07, 2017
Forge Therapeutics And Evotec Present Efficacy Data For LpxC Inhibitor In Urinary Tract, Lung, Thigh, And Abdominal Infection Models At ASM ESCMID 2017
Jul 26, 2017
Forge Therapeutics Forms Scientific Advisory Board with World Renowned Antibiotic and Drug Development Experts
Jun 12, 2017
Forge Therapeutics To Present At 2017 BIO International Convention
Jun 03, 2017
Forge Therapeutics And Evotec Present First Efficacy Data For LpxC Inhibitor In UTI Model At ASM Microbe 2017